Na Li

Na Li

Auto-generated profile, based on publicly available information

Na Li

Department of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, P. R. China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2025 in Phytomedicine
Verified
Journal Article
Closed access
JZJunli Zhang
Junli Zhang
LHLiyuan Hao
Liyuan Hao
SLShenghao Li
Shenghao Li
YHYing He
Ying He
YZYang Zhang
Yang Zhang
XHXiaoyu Hu
Xiaoyu Hu

1 January 2024 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
JZJunli Zhang
Junli Zhang
NLNa Li
Na Li
XHXiaoyu Hu
Xiaoyu Hu
Acute liver failure (ALF) is a fulminant clinical syndrome that usually leads to multiple organ failure and high mortality. Macrophages play a crucial role in the initiation, development, and recovery of ALF. Targeting macrophages through immunotherapy holds significant promise as a therapeutic strategy. These cells exhibit remarkable plasticity, enabling them to differentiate into various subtypes based on changes in their surrounding microenvironment. M1‐type macrophages are associated with a pro‐inflammatory phenotype and primarily rely predominantly on glycolysis. In contrast, M2‐type macrophages, which are characterized by anti‐inflammatory phenotype, predominantly obtain their energy from oxidative phosphorylation (OXPHOS) and fatty acid oxidation (FAO). Shifting macrophage metabolism from glycolysis to OXPHOS inhibits M1 macrophage activation and promotes M2 macrophage activation, thereby exerting anti‐inflammatory and reparative effects. This study elucidates the relationship between macrophage activation and glucose metabolism reprograming from an immunometabolism perspective. A comprehensive literature review revealed that several signaling pathways may regulate macrophage polarization through energy metabolism, including phosphatidyl‐inositol 3‐kinase/protein kinase B (PI3K/AKT), mammalian target of rapamycin (mTOR)/hypoxia‐inducible factor 1α (HIF‐1α), nuclear factor‐κB (NF‐κB), and AMP‐activated protein kinase (AMPK), which exhibit crosstalk with one another. Additionally, we systematically reviewed several traditional Chinese medicine (TCM) monomers that can modulate glucose metabolism reprograming and influence the polarization states of M1 and M2 macrophages. This review aimed to provide valuable insights that could contribute to the development of new therapies or drugs for ALF.

16 June 2026 in The American Journal of Chinese Medicine
Verified
Journal Article
Closed access
NLNa Li
Na Li
FYFanghang Ye
Fanghang Ye
FYFei Yu
Fei Yu
LHLiyuan Hao
Liyuan Hao
SLShenghao Li
Shenghao Li
XHXiaoyu Hu
Xiaoyu Hu